DK205376A - Fremgangsmade til fremstilling af oralt indgivelige tabletter, der har et hojt indhold af vandoploselige xanthinderivater - Google Patents

Fremgangsmade til fremstilling af oralt indgivelige tabletter, der har et hojt indhold af vandoploselige xanthinderivater

Info

Publication number: DK205376A
Authority: DK; Denmark
Prior art keywords: submissible; orally; tablets; soluble; procedure
Prior art date: 1975-05-10

Application number

DK205376A

Other languages

English (en)

Other versions

DK153918B (da

DK153918C (da

Inventor

Klaus Gleixner

Roland Mueller

Franz Lehrach

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-05-10

Filing date

1976-05-07

Publication date

1976-11-11

1976-05-07 Application filed by Hoechst Ag filed Critical Hoechst Ag

1976-11-11 Publication of DK205376A publication Critical patent/DK205376A/da

1988-09-26 Publication of DK153918B publication Critical patent/DK153918B/da

1989-02-06 Application granted granted Critical

1989-02-06 Publication of DK153918C publication Critical patent/DK153918C/da

Links

LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK205376A 1975-05-10 1976-05-07 Fremgangsmaade til fremstilling af oralt indgivelige tabletter, der hver har hoejt indhold af vandoploeselige xanthinderivater DK153918C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE2520978A DE2520978C3 (de)	1975-05-10	1975-05-10	Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
DE2520978		1975-05-10

Publications (3)

Publication Number	Publication Date
DK205376A true DK205376A (da)	1976-11-11
DK153918B DK153918B (da)	1988-09-26
DK153918C DK153918C (da)	1989-02-06

Family

ID=5946306

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK205376A DK153918C (da)	1975-05-10	1976-05-07	Fremgangsmaade til fremstilling af oralt indgivelige tabletter, der hver har hoejt indhold af vandoploeselige xanthinderivater

Country Status (12)

Country	Link
US (1)	US4189469A (da)
AU (1)	AU502644B2 (da)
BE (1)	BE841617A (da)
CY (1)	CY1153A (da)
DE (1)	DE2520978C3 (da)
DK (1)	DK153918C (da)
FR (1)	FR2310764A1 (da)
GB (1)	GB1547232A (da)
HK (1)	HK42382A (da)
KE (1)	KE3219A (da)
MY (1)	MY8600617A (da)
ZA (1)	ZA762748B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4491539A (en) *	1981-06-04	1985-01-01	The Procter & Gamble Company	Liquid cleansing product with skin feel additives
DE3127237A1 (de) *	1981-07-10	1983-01-20	Hoechst Ag, 6000 Frankfurt	Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
US4636507A (en) *	1984-04-30	1987-01-13	Hoechst-Roussel Pharmaceuticals Inc.	Host defense mechanism enhancement
DE3508097A1 (de) *	1984-07-21	1986-02-06	Hoechst Ag, 6230 Frankfurt	Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
EP0222883A1 (en) *	1985-05-15	1987-05-27	Riker Laboratories, Inc.	Sustained release theophylline compositions and processes
GB8628359D0 (en) *	1986-11-27	1986-12-31	Zyma Sa	Galenical formulation
US5200193A (en) *	1987-04-22	1993-04-06	Mcneilab, Inc.	Pharmaceutical sustained release matrix and process
US4820522A (en) *	1987-07-27	1989-04-11	Mcneilab, Inc.	Oral sustained release acetaminophen formulation and process
US5085865A (en) *	1989-04-12	1992-02-04	Warner-Lambert Company	Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5112827A (en) *	1990-05-18	1992-05-12	Board Of Regents, The University Of Texas System	Drug to reverse fatty liver and atheromatous lesions
FR2677886B1 (fr) *	1991-06-18	1995-03-31	Adir	Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5498802A (en) *	1995-02-28	1996-03-12	Hoechst Celanese Corporation	Process for preparing omega-halo-ketones
US20040209900A1 (en) *	2003-04-15	2004-10-21	Hauptman Stephen P.	Treatment of lipodystrophy (lipid redistribution syndrome)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3065143A (en) *	1960-04-19	1962-11-20	Richardson Merrell Inc	Sustained release tablet
DE1617418C3 (de) *	1967-12-16	1980-01-24	Hoechst Ag, 6000 Frankfurt	Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
US3864469A (en) *	1967-12-16	1975-02-04	Hoechst Ag	Xanthines in pharmaceutical preparations and for stabilization of vitamins
US3577514A (en) *	1968-06-10	1971-05-04	Pfizer	Sustained release pharmaceutical tablets
US3590117A (en) *	1969-03-24	1971-06-29	Richardson Merrell Inc	Long-lasting troche containing guar gum
US3639169A (en) *	1969-04-29	1972-02-01	Sucrest Corp	Direct compression vehicles and method therefor

1975
- 1975-05-10 DE DE2520978A patent/DE2520978C3/de not_active Expired
1976
- 1976-05-06 US US05/683,795 patent/US4189469A/en not_active Expired - Lifetime
- 1976-05-07 BE BE166873A patent/BE841617A/xx not_active IP Right Cessation
- 1976-05-07 DK DK205376A patent/DK153918C/da not_active IP Right Cessation
- 1976-05-07 ZA ZA762748A patent/ZA762748B/xx unknown
- 1976-05-07 FR FR7613720A patent/FR2310764A1/fr active Granted
- 1976-05-10 AU AU13765/76A patent/AU502644B2/en not_active Expired
- 1976-05-10 GB GB19162/76A patent/GB1547232A/en not_active Expired
- 1976-05-10 CY CY1153A patent/CY1153A/xx unknown
1982
- 1982-07-07 KE KE3219A patent/KE3219A/xx unknown
- 1982-09-30 HK HK423/82A patent/HK42382A/xx unknown
1986
- 1986-12-30 MY MY617/86A patent/MY8600617A/xx unknown

Also Published As

Publication number	Publication date
FR2310764A1 (fr)	1976-12-10
US4189469A (en)	1980-02-19
ZA762748B (en)	1977-04-27
BE841617A (fr)	1976-11-08
AU502644B2 (en)	1979-08-02
DE2520978C3 (de)	1981-02-19
AU1376576A (en)	1977-11-17
DK153918B (da)	1988-09-26
CY1153A (en)	1982-09-10
KE3219A (en)	1982-08-13
DE2520978B2 (de)	1980-06-12
HK42382A (en)	1982-10-08
GB1547232A (en)	1979-06-06
DK153918C (da)	1989-02-06
FR2310764B1 (da)	1980-07-11
DE2520978A1 (de)	1976-11-18
MY8600617A (en)	1986-12-31

Similar Documents

Publication	Publication Date	Title
DK298176A (da)	1977-01-03	Fremgangsmade til fremstilling af 1,4-dihydropyrinderivater
DK494876A (da)	1977-05-08	Fremgangsmade til fremstilling af piperidinderivater
DK562376A (da)	1977-06-24	Fremgangsmade til fremstilling af ergolinderivater
DK205376A (da)	1976-11-11	Fremgangsmade til fremstilling af oralt indgivelige tabletter, der har et hojt indhold af vandoploselige xanthinderivater
DK462376A (da)	1977-04-17	Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater
MX3639E (es)	1981-04-13	Procedimiento para la preparacion de un derivado de la 1,5,10,10a-tetrahidro(3,4-b) tiazolo isoquinoleina
DK154976C (da)	1989-06-05	Fremgangsmaade til fremstilling af 5-aroyl-1-laverealkylpyrrol-2-eddikesyrederivater
DK139267B (da)	1979-01-22	Fremgangsmaade til fremstilling af 4-androsten3,17-dionderivater
DK324176A (da)	1977-01-18	Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK528976A (da)	1977-06-04	Fremgangsmade til fremstilling af indazolderivater
DK298476A (da)	1977-01-05	Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK98076A (da)	1976-09-08	Fremgangsmade til fremstilling af et farmaceutisk preparat
DK276276A (da)	1976-12-20	Fremgangsmade til fremstilling af 2-substituerede 1-(omega-aminoalkoxy)benzenderivater
DK137275C (da)	1978-07-17	Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK343976A (da)	1977-02-02	Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
DK251176A (da)	1976-12-10	Fremgangsmade til fremstilling af cyklopropanolderivater
DK551076A (da)	1977-06-23	Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
AR211854A1 (es)	1978-03-31	Procedimiento de preparacion de derivados polisustituidos de 10-piperazinodibenzo(b,f)tiepina
DK253676A (da)	1976-12-17	Fremgangsmade til fremstilling af cycloheptathiopenderivater
DK66376A (da)	1976-08-20	Fremgangsmade til fremstilling af et hidtil ukendt dimercaptoethyletherderivat
DK140576A (da)	1976-11-10	Fremgangsmade til fremstilling af 21-hydroxy-16-pregnen-20-on-derivater
DK305076A (da)	1977-01-08	Fremgangsmade til fremstilling af d,l-pantolacton
DK192576A (da)	1976-10-31	Fremgangsmade til fremstilling af 7-methoxycephalosporin-derivater
DK139269B (da)	1979-01-22	Fremgangsmaade til fremstilling af 4-androsten3,17-dionderivatier
DK136653B (da)	1977-11-07	Fremgangsmåde til fremstilling af thieno-pyridinderivater.

Legal Events

Date	Code	Title	Description
1996-06-10	PUP	Patent expired